B-MoGen Biotechnologies, Inc.

Biotechnology company · St. Paul, Minnesota, United States

B-MoGen Biotechnologies, Inc. is a biotechnology company headquartered in St. Paul, Minnesota, United States. Its earliest recorded incorporation is in 2015. It has received 5 US government small-business research awards (SBIR/STTR) from health agencies, $2.3 million in total, most recently in 2019. It has reported private securities offerings to the US SEC, most recently $1 million sold in a notice filed in 2016.

Profile compiled from public records. Is this your company? Request a correction or update

B-MoGen Biotechnologies at a glance

Typebiotechnology company
HeadquartersSt. Paul, Minnesota, United States
Earliest incorporation on record2015
Employees (self-reported, 2019)1
SEC CIK1674596

What does B-MoGen Biotechnologies do?

US government research funding

5 SBIR/STTR small-business research awards from US health agencies, $2.3 million in total (2017 to 2019). NIH funding came from the National Cancer Institute, National Heart, Lung, and Blood Institute, National Institute of General Medical Sciences.

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $1 million sold (2016).

Frequently asked questions about B-MoGen Biotechnologies

Where is B-MoGen Biotechnologies headquartered?

B-MoGen Biotechnologies, Inc. is headquartered in St. Paul, Minnesota, United States.

What does B-MoGen Biotechnologies do?

B-MoGen Biotechnologies, Inc. is a biotechnology company.

When was B-MoGen Biotechnologies founded?

The earliest incorporation on record for B-MoGen Biotechnologies, Inc. is in 2015, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences